HRP20041150B1 - Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women - Google Patents

Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women

Info

Publication number: HRP20041150B1
Authority: HR; Croatia
Prior art keywords: toremifene; tore; urgency; atrophy; urinary
Prior art date: 2002-06-06

Application number

HR20041150A

Other languages

English (en)

Croatian (hr)

Inventor

Blom Taru

Gr�nroos Paula

Halonen Kaija

H�rk�nen Pirkko

Original Assignee

Hormos Medical Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-06

Filing date

2004-12-02

Publication date

2007-06-30

2004-12-02 Application filed by Hormos Medical Corporation filed Critical Hormos Medical Corporation

2006-03-31 Publication of HRP20041150A2 publication Critical patent/HRP20041150A2/xx

2007-06-30 Publication of HRP20041150B1 publication Critical patent/HRP20041150B1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Gynecology & Obstetrics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Medicinal Preparation (AREA)

HR20041150A 2002-06-06 2004-12-02 Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women HRP20041150B1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US38590402P	2002-06-06	2002-06-06
PCT/FI2003/000369 WO2003103649A1 (en)	2002-06-06	2003-05-14	Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women

Publications (2)

Publication Number	Publication Date
HRP20041150A2 HRP20041150A2 (en)	2006-03-31
HRP20041150B1 true HRP20041150B1 (en)	2007-06-30

Family

ID=29736123

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20041150A HRP20041150B1 (en)	2002-06-06	2004-12-02	Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women

Country Status (24)

Country	Link
EP (1)	EP1509215B1 (no)
JP (1)	JP4362442B2 (no)
KR (1)	KR100991157B1 (no)
CN (2)	CN101406464A (no)
AT (1)	ATE344025T1 (no)
AU (1)	AU2003227790B2 (no)
BR (1)	BR0311613A (no)
CA (1)	CA2484542C (no)
CY (1)	CY1105787T1 (no)
DE (1)	DE60309465T2 (no)
DK (1)	DK1509215T3 (no)
ES (1)	ES2270025T3 (no)
HR (1)	HRP20041150B1 (no)
IL (1)	IL164528A (no)
MX (1)	MXPA04012220A (no)
NO (3)	NO334090B1 (no)
NZ (1)	NZ536118A (no)
PL (1)	PL214242B1 (no)
PT (1)	PT1509215E (no)
RU (1)	RU2317816C2 (no)
SI (1)	SI1509215T1 (no)
UA (1)	UA79797C2 (no)
WO (1)	WO2003103649A1 (no)
ZA (1)	ZA200408321B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8236861B2 (en)	2004-02-13	2012-08-07	Hormos Medical Corporation	Method for enhancing the bioavailablity of ospemifene
US8642079B2 (en)	2004-02-23	2014-02-04	Hormos Medical Corporation	Solid formulations of ospemifene
WO2005105052A1 (en) *	2004-05-04	2005-11-10	Hormos Medical Ltd.	Novel oral formulations of ospemifene
US8758821B2 (en)	2004-05-04	2014-06-24	Hormos Medical Ltd.	Oral formulations of ospemifene
CA2654152A1 (en)	2006-06-02	2007-12-13	Pear Tree Women's Health Care	Method of treating atrophic vaginitis
SI2518039T1 (sl)	2007-02-14	2015-02-27	Forendo Pharma Ltd.	Postopek za pripravo terapevtsko dragocenih derivatov trifenilbutena
US7504530B2 (en)	2007-02-14	2009-03-17	Hormos Medical Ltd.	Methods for the preparation of fispemifene from ospemifene
US9321712B2 (en)	2012-10-19	2016-04-26	Fermion Oy	Process for the preparation of ospemifene
KR102052133B1 (ko)	2017-08-10	2019-12-05	고려대학교 산학협력단	당 부가된 오스페미펜, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5352699A (en) *	1992-04-30	1994-10-04	University Of Massachusetts Medical Center	Use of retinioc acid to treat vaginal atrophy
US5461064A (en) *	1993-12-21	1995-10-24	Eli Lilly And Company	Methods of inhibiting atrophy of the skin and vagina
US5747059A (en) *	1996-01-11	1998-05-05	Novo Nordisk A/S	Atrophy of skin/mucous membrane
JP2003520817A (ja) *	2000-01-28	2003-07-08	エンドルシェルシェ，インコーポレイテッド．	エストロゲンと組み合わせた選択的エストロゲン受容体モジュレータ
US20010034340A1 (en) *	2000-03-20	2001-10-25	American Home Products Corporation	Hormone replacement therapy
US6245819B1 (en) *	2000-07-21	2001-06-12	Hormos Medical Oy, Ltd.	Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause

2003
- 2003-05-14 MX MXPA04012220A patent/MXPA04012220A/es active IP Right Grant
- 2003-05-14 JP JP2004510768A patent/JP4362442B2/ja not_active Expired - Lifetime
- 2003-05-14 CA CA2484542A patent/CA2484542C/en not_active Expired - Lifetime
- 2003-05-14 SI SI200330601T patent/SI1509215T1/sl unknown
- 2003-05-14 UA UAA200500144A patent/UA79797C2/uk unknown
- 2003-05-14 WO PCT/FI2003/000369 patent/WO2003103649A1/en active IP Right Grant
- 2003-05-14 BR BR0311613-1A patent/BR0311613A/pt not_active Application Discontinuation
- 2003-05-14 DK DK03725238T patent/DK1509215T3/da active
- 2003-05-14 CN CNA2008101733358A patent/CN101406464A/zh active Pending
- 2003-05-14 AU AU2003227790A patent/AU2003227790B2/en not_active Expired
- 2003-05-14 PT PT03725238T patent/PT1509215E/pt unknown
- 2003-05-14 NZ NZ536118A patent/NZ536118A/en not_active IP Right Cessation
- 2003-05-14 EP EP03725238A patent/EP1509215B1/en not_active Expired - Lifetime
- 2003-05-14 PL PL372758A patent/PL214242B1/pl unknown
- 2003-05-14 KR KR1020047019843A patent/KR100991157B1/ko active IP Right Grant
- 2003-05-14 DE DE60309465T patent/DE60309465T2/de not_active Expired - Lifetime
- 2003-05-14 CN CNB038128780A patent/CN100448437C/zh not_active Expired - Lifetime
- 2003-05-14 ES ES03725238T patent/ES2270025T3/es not_active Expired - Lifetime
- 2003-05-14 RU RU2004138571/14A patent/RU2317816C2/ru active
- 2003-05-14 AT AT03725238T patent/ATE344025T1/de active
2004
- 2004-10-12 IL IL164528A patent/IL164528A/en active IP Right Grant
- 2004-10-14 ZA ZA200408321A patent/ZA200408321B/en unknown
- 2004-10-22 NO NO20044568A patent/NO334090B1/no not_active IP Right Cessation
- 2004-12-02 HR HR20041150A patent/HRP20041150B1/xx not_active IP Right Cessation
2006
- 2006-11-15 CY CY20061101664T patent/CY1105787T1/el unknown
2013
- 2013-09-04 NO NO20131189A patent/NO336612B1/no not_active IP Right Cessation
2015
- 2015-04-22 NO NO20150487A patent/NO339194B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
UA79797C2 (en)	2007-07-25
EP1509215B1 (en)	2006-11-02
CN1658851A (zh)	2005-08-24
NO334090B1 (no)	2013-12-09
ATE344025T1 (de)	2006-11-15
PL214242B1 (pl)	2013-07-31
PL372758A1 (en)	2005-08-08
MXPA04012220A (es)	2005-04-08
RU2317816C2 (ru)	2008-02-27
NO20044568L (no)	2004-12-22
IL164528A0 (en)	2005-12-18
PT1509215E (pt)	2007-01-31
ES2270025T3 (es)	2007-04-01
CY1105787T1 (el)	2011-02-02
HRP20041150A2 (en)	2006-03-31
KR20050004292A (ko)	2005-01-12
DE60309465T2 (de)	2007-08-30
CN101406464A (zh)	2009-04-15
NO20131189L (no)	2004-12-22
CA2484542A1 (en)	2003-12-18
AU2003227790A1 (en)	2003-12-22
EP1509215A1 (en)	2005-03-02
NO339194B1 (no)	2016-11-14
CA2484542C (en)	2010-11-02
NZ536118A (en)	2007-08-31
NO336612B1 (no)	2015-10-12
AU2003227790B2 (en)	2007-11-29
KR100991157B1 (ko)	2010-11-02
DK1509215T3 (da)	2007-03-12
ZA200408321B (en)	2006-07-26
CN100448437C (zh)	2009-01-07
RU2004138571A (ru)	2005-06-10
JP2005532353A (ja)	2005-10-27
WO2003103649A1 (en)	2003-12-18
NO20150487L (no)	2004-12-22
JP4362442B2 (ja)	2009-11-11
DE60309465D1 (de)	2006-12-14
SI1509215T1 (sl)	2007-02-28
BR0311613A (pt)	2005-03-08
IL164528A (en)	2010-06-30

Similar Documents

Publication	Publication Date	Title
Soloway	1980	Rationale for intensive intravesical chemotherapy for superficial bladder cancer
MA25809A1 (fr)	2003-07-01	Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase
ATE378058T1 (de)	2007-11-15	Cannabis extrakten pharmazeutische zusammensetzung
WO2001062236A3 (en)	2002-03-07	New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent
CA2275663A1 (en)	1998-07-02	Pharmaceutical compositions comprising .alpha.-adrenergic agonists for the treatment of fecal incontinence
BRPI0408556A (pt)	2006-03-21	formulações dispersìvel de um agente antiinflamatório
HK1087702A1 (en)	2006-10-20	Arylmethylamine derivatives for use as tryptase inhibitors
EA200900491A1 (ru)	2009-10-30	Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола
EA200601802A1 (ru)	2007-02-27	Производные морфолина
HRP20041150B1 (en)	2007-06-30	Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women
RU2007132725A (ru)	2009-03-10	Применение неопиатного анальгетика флупиртина для лечения гиперактивности мочевого пузыря и родственных заболеваний, в том числе неотложного недержания мочи, проблем с мочеотделением, как результата гиперплазии предстательной железы и синдрома раздраженного кишечника
RU2009120990A (ru)	2010-12-10	Применение тестостерона и агониста 5-нт1а для лечения сексуальной дисфункции
EE05344B1 (et)	2010-10-15	Ühendi (deaminohüdroksü)toremifeeni kasutamine tupekuivuse v?i seksuaaldüsfunktsiooni ravis menopausi ajal v?i järel
WO2001017479B1 (en)	2002-02-07	Methods and compositions for preventing and treating prostate disorders
KR20100117081A (ko)	2010-11-02	양성 전립선 비대증, 전립선염, 전립선증 및 전립선 암 치료용 조성물
JP2009537629A (ja)	2009-10-29	選択的エストロゲン受容体モジュレーターまたはアロマターゼ阻害剤を用いた慢性非細菌性前立腺炎の治療方法
HRP20090022T3 (en)	2009-02-28	Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences
HUP0402358A2 (hu)	2005-03-29	Szelektív dopamin D4 receptor agonisták alkalmazása szexuális diszfunkciók kezelésére alkalmas gyógyszerkészítmény előállítására
RU2372933C1 (ru)	2009-11-20	Лекарственное средство и лекарственная композиция для его изготовления
RU2002109259A (ru)	2003-12-10	Способ лечения доброкачественных заболеваний шейки матки
EA200600156A1 (ru)	2006-08-25	Пероральная дозировочная форма саквинавирмезилата
CA2588017A1 (en)	2006-06-22	Use of alpha-adrenergic blockers for the treatment of dysmenorrhea
WO2004014360A3 (fr)	2004-04-08	Compositions pharmaceutiques destinees au traitement de l'incontinence urinaire
PT1347753E (pt)	2006-07-31	Composicao topica e metodo para o tratamento da incontinencia urinaria de stress
US20050165090A1 (en)	2005-07-28	Polyphenols as an intravesical agent for the prevention of transitional cell tumor implantation

Legal Events

Date	Code	Title	Description
2006-03-31	A1OB	Publication of a patent application
2006-09-27	ARAI	Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
2007-06-30	B1PR	Patent granted
2019-05-31	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20190507 Year of fee payment: 17
2020-05-29	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20200505 Year of fee payment: 18
2021-05-28	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20210505 Year of fee payment: 19
2022-06-24	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20220506 Year of fee payment: 20
2023-05-15	PB20	Patent expired after termination of 20 years	Effective date: 20230514